Burgess Statement on DEA Withdrawal of Kratom Ban
Washington, October 13, 2016 | Lesley Fulop (202-225-7772)
Tags: Food and Product Safety
Washington, D.C. – Congressman Michael C. Burgess, M.D. (R-TX), Chairman of the House Energy and Commerce Subcommittee on Commerce, Manufacturing and Trade, issued the following statement about the Drug Enforcement Administration’s (DEA) intent to place the active materials in kratom, Mitragynine and 7-hydroxymitragynine, in the Schedule I category of controlled substances.
"The DEA announced on August 31, 2016, it intended to temporarily classify kratom as a Schedule I drug. Under current law, the DEA does have the authority to place a substance under a temporary schedule for up to two years, if that substance is deemed an imminent hazard to public safety. The DEA stated this decision was due to the fact that kratom was commonly marketed as a legal alternative to illegal substances. Additionally, law enforcement has seen a drastic increase in kratom trafficking and usage.
Latest from twitter
Get the most up to date news from me on Twitter.